Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma

NACompletedINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

July 31, 1999

Study Completion Date

December 31, 2005

Conditions

Classical Hodgkin LymphomaNodular SclerosisMixed CellularityLymphocyte DepletionLymphocyte Rich

Interventions

PROCEDURE

interim therapy scintigraphy study gallium scan or PET/CT

PROCEDURE

"interim gallium or PET/CT"

Trial Locations (1)

Eldad Dann, Haifa

All Listed Sponsors

lead

Rambam Health Care Campus

OTHER

NCT00305149 - Risk Adapted Beacopp Regimen for Standard and High Risk Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter